What Is Melanotan I?
Melanotan I (MT-1) is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) developed for melanocortin and pigmentation-related research.
The peptide is also associated in scientific literature with NDP-α-MSH, a modified α-MSH sequence designed to provide greater stability than the endogenous hormone.
SUNONE supplies Melanotan I, CAS 75921-69-6, as ≥99% HPLC lyophilized Research Grade material for qualified laboratory, analytical and manufacturing research.
SUNONE Melanotan I Product Page:
Why Is Melanotan I Different From Natural Alpha-MSH?
Natural α-MSH participates in melanocortin signaling but is relatively susceptible to biological degradation.
Melanotan I incorporates structural modifications to the α-MSH sequence.
Research literature describes substitutions including:
- norleucine at position 4;
- D-phenylalanine at position 7.
These changes produced the peptide historically described as [Nle4, D-Phe7]-α-MSH.
For researchers, this means Melanotan I should be considered an engineered melanocortin peptide rather than simply “synthetic natural MSH.”
A more useful molecular framework is:
α-MSH → modified peptide sequence → melanocortin receptor signaling → melanocyte biology → eumelanin research.
Melanotan I and Afamelanotide: Why Product Identity Matters
Melanotan I and afamelanotide are closely related terms in the scientific history of this molecule.
Afamelanotide is the active substance in the regulated pharmaceutical product SCENESSE, which is approved for a specific medical use involving erythropoietic protoporphyria.
However, the existence of an approved afamelanotide medicine does not mean that every product labeled:
- Melanotan I;
- MT-1;
- NDP-MSH;
- afamelanotide analog
is automatically equivalent to SCENESSE.
Pharmaceutical equivalence depends on far more than the peptide name.
It includes defined active substance identity, formulation, manufacturing controls, impurities, stability and regulatory specifications.
Therefore, clinical findings involving SCENESSE should not automatically be attributed to SUNONE Research Grade Melanotan I.
Melanotan I vs Melanotan II
Melanotan I and Melanotan II are different molecules.
Although both originated from melanocortin research, their structures and pharmacological profiles are not interchangeable.
Melanotan I is derived from a modified α-MSH sequence.
Melanotan II is a shorter cyclic melanocortin analog with a broader biological research profile.
This distinction is particularly important for Google searches because “MT-1” and “MT-2” are frequently discussed together.
For laboratory research:
Melanotan I evidence ≠ Melanotan II evidence.
Studies or side-effect discussions involving MT-2 should not automatically be used as evidence for MT-1.
Why Is Melanocortin Signaling Important?
Melanocortin receptors participate in several biological pathways.
In pigmentation-related research, the MC1R pathway is especially relevant because signaling in melanocytes can influence:
- melanogenesis;
- eumelanin production;
- tyrosinase-related pathways;
- pigmentation biology;
- cellular responses associated with UV exposure.
This is why Melanotan I is better described as a melanocortin research peptide than simply as a “tanning peptide.”
The receptor pathway provides the scientific context.
What Do Melanotan I Reviews Say?
Current online Melanotan I reviews are mixed.
Positive anecdotal reports sometimes mention:
- more noticeable pigmentation;
- darker skin appearance;
- gradual tanning response;
- fewer subjective unwanted effects than experienced with MT-2.
Negative or neutral reports include:
- little or no noticeable effect;
- slower-than-expected pigmentation;
- nausea;
- darker freckles or moles;
- concerns about long-term skin effects.
Individual reports vary considerably.
Some users who report strong pigmentation changes also describe substantial UV exposure, while others discuss multiple compounds or products from unverified sources.
This makes causality impossible to establish from online reviews.
Melanotan I reviews should therefore be treated as anecdotal search sentiment, not clinical evidence.
Does Approved Afamelanotide Prove That Research-Grade MT-1 Is Safe?
No.
This is one of the most important distinctions in Melanotan I research.
FDA- and EMA-authorized SCENESSE is a regulated pharmaceutical product containing afamelanotide for a defined indication.
SUNONE Melanotan I is supplied as Research Grade material.
Clinical approval of a finished pharmaceutical formulation does not establish the:
- safety;
- efficacy;
- bioavailability;
- formulation equivalence;
- pharmaceutical quality
of a research-grade product.
Researchers should keep these product categories separate.
What Should Researchers Check When Choosing a Melanotan I Supplier?
For professional Melanotan I research, the product name alone is insufficient.
Molecular Identity
The material should correspond to the intended MT-1 molecular entity.
HPLC Purity
Batch-specific chromatographic data should support the reported peptide purity.
Molecular Mass
Analytical characterization should be consistent with the expected molecular specification.
Batch-Specific COA
A current Melanotan I COA helps support lot-level traceability.
Clear Terminology
Researchers should determine exactly what a supplier means when using terms such as:
Melanotan I, MT-1, NDP-MSH, afamelanotide or afamelanotide analog.
SUNONE currently lists:
Product: Melanotan I (MT-1)
Synonyms: Melanotan I, MT-1, Melanotan-1, Afamelanotide Research Analog, Alpha-MSH Analog
CAS: 75921-69-6
Formula: C78H111N21O19
Molecular Weight: 1646.9 g/mol
Purity: ≥99% HPLC
Form: Lyophilized Powder
Grade: Research Grade
Melanotan I Research: Follow the Molecular Identity
A common search question is:
“Is Melanotan I the same as Melanotan II?”
A more useful research question is:
“Which molecular entity and melanocortin pathway produced the published result?”
That creates a clearer scientific framework:
α-MSH → Melanotan I / NDP-MSH → melanocortin signaling → melanocyte biology → pigmentation research.
For laboratories evaluating a research-grade Melanotan I supplier, molecular identity, HPLC purity and batch-specific analytical documentation should take priority over generalized cosmetic or tanning claims.
SUNONE research peptide is for qualified labrtorynt, diagnois, druc tor mmatct or veteimant, use.research only, Not for human consumption, clinical treame.
Leave a Reply